[go: up one dir, main page]

MX2020000807A - Proceso para preparar una composicion de entrega de farmaco. - Google Patents

Proceso para preparar una composicion de entrega de farmaco.

Info

Publication number
MX2020000807A
MX2020000807A MX2020000807A MX2020000807A MX2020000807A MX 2020000807 A MX2020000807 A MX 2020000807A MX 2020000807 A MX2020000807 A MX 2020000807A MX 2020000807 A MX2020000807 A MX 2020000807A MX 2020000807 A MX2020000807 A MX 2020000807A
Authority
MX
Mexico
Prior art keywords
polymer
preparing
drug delivery
delivery composition
drug
Prior art date
Application number
MX2020000807A
Other languages
English (en)
Inventor
Philippe Pouletty
Frédérique Guillamot
Original Assignee
PK Med SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PK Med SAS filed Critical PK Med SAS
Publication of MX2020000807A publication Critical patent/MX2020000807A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L17/00—Materials for surgical sutures or for ligaturing blood vessels ; Materials for prostheses or catheters
    • A61L17/06—At least partially resorbable materials
    • A61L17/10—At least partially resorbable materials containing macromolecular materials
    • A61L17/12—Homopolymers or copolymers of glycolic acid or lactic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A61L24/0015—Medicaments; Biocides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/046—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/18—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L27/54—Biologically active materials, e.g. therapeutic substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/04—Macromolecular materials
    • A61L31/06—Macromolecular materials obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L31/00—Materials for other surgical articles, e.g. stents, stent-grafts, shunts, surgical drapes, guide wires, materials for adhesion prevention, occluding devices, surgical gloves, tissue fixation devices
    • A61L31/14—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
    • A61L31/16—Biologically active materials, e.g. therapeutic substances
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29C—SHAPING OR JOINING OF PLASTICS; SHAPING OF MATERIAL IN A PLASTIC STATE, NOT OTHERWISE PROVIDED FOR; AFTER-TREATMENT OF THE SHAPED PRODUCTS, e.g. REPAIRING
    • B29C48/00—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor
    • B29C48/022—Extrusion moulding, i.e. expressing the moulding material through a die or nozzle which imparts the desired form; Apparatus therefor characterised by the choice of material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
    • C07K16/241—Tumor Necrosis Factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/216—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials with other specific functional groups, e.g. aldehydes, ketones, phenols, quaternary phosphonium groups
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/20—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices containing or releasing organic materials
    • A61L2300/252—Polypeptides, proteins, e.g. glycoproteins, lipoproteins, cytokines
    • A61L2300/254—Enzymes, proenzymes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2067/00—Use of polyesters or derivatives thereof, as moulding material
    • B29K2067/04—Polyesters derived from hydroxycarboxylic acids
    • B29K2067/043—PGA, i.e. polyglycolic acid or polyglycolide
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2067/00—Use of polyesters or derivatives thereof, as moulding material
    • B29K2067/04—Polyesters derived from hydroxycarboxylic acids
    • B29K2067/046—PLA, i.e. polylactic acid or polylactide
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0005—Condition, form or state of moulded material or of the material to be shaped containing compounding ingredients
    • B29K2105/0035—Medical or pharmaceutical agents
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B29—WORKING OF PLASTICS; WORKING OF SUBSTANCES IN A PLASTIC STATE IN GENERAL
    • B29K—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES B29B, B29C OR B29D, RELATING TO MOULDING MATERIALS OR TO MATERIALS FOR MOULDS, REINFORCEMENTS, FILLERS OR PREFORMED PARTS, e.g. INSERTS
    • B29K2105/00—Condition, form or state of moulded material or of the material to be shaped
    • B29K2105/0085—Copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Transplantation (AREA)
  • Materials Engineering (AREA)
  • Emergency Medicine (AREA)
  • Mechanical Engineering (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere al proceso para preparar una composición de entrega de fármaco que comprende las etapas de a) preparar una mezcla madre que comprende un fármaco y un primer polímero (i) extruyendo el primer polímero, en donde dicho primer polímero tiene una temperatura de fusión inferior a 140 ºC; y (ii) introduciendo el fármaco durante la extrusión del primer polímero, con un contenido de fármaco de entre el 0,1 % y el 90 %, basándose en el peso total de la mezcla madre; y b) introducir la mezcla madre en una matriz a base de polímero durante la producción de la composición de entrega de fármaco, en donde la etapa a) se realiza a una temperatura a la que el primer polímero está en un estado parcial o totalmente fundido y la etapa b) se realiza a una temperatura a la que tanto el primer polímero como al menos un polímero de la matriz a base de polímero están en un estado parcial o totalmente fundido.
MX2020000807A 2017-07-25 2018-07-25 Proceso para preparar una composicion de entrega de farmaco. MX2020000807A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17305993 2017-07-25
PCT/EP2018/070139 WO2019020678A1 (en) 2017-07-25 2018-07-25 PROCESS FOR PREPARING A DRUG DELIVERY COMPOSITION

Publications (1)

Publication Number Publication Date
MX2020000807A true MX2020000807A (es) 2020-08-17

Family

ID=59579573

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020000807A MX2020000807A (es) 2017-07-25 2018-07-25 Proceso para preparar una composicion de entrega de farmaco.

Country Status (13)

Country Link
US (1) US11911476B2 (es)
EP (1) EP3658117A1 (es)
JP (1) JP7373486B2 (es)
KR (1) KR20200040776A (es)
CN (1) CN111065378A (es)
AU (1) AU2018305160A1 (es)
BR (1) BR112020001262A2 (es)
CA (1) CA3069399A1 (es)
MX (1) MX2020000807A (es)
RU (1) RU2020107391A (es)
SG (1) SG11202000497VA (es)
WO (1) WO2019020678A1 (es)
ZA (1) ZA202001046B (es)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11773257B2 (en) * 2017-08-31 2023-10-03 Carbiolice Biodegradable polyester article comprising enzymes
JP2022526952A (ja) 2019-03-28 2022-05-27 ピーケイ・メッド 多成分熱可塑性製品
CN110237308B (zh) * 2019-06-06 2021-05-18 中南大学湘雅二医院 一种用于修复肿瘤性骨缺损的人工骨及其制备方法
WO2021053167A1 (de) * 2019-09-19 2021-03-25 Amw Gmbh Extrudierte depotform mit kontrollierter wirkstofffreisetzung
WO2021123328A1 (en) 2019-12-19 2021-06-24 Carbios Foamed plastic compositions
KR20230054437A (ko) * 2020-08-21 2023-04-24 메레디언, 인크. 식품 접촉 물품을 위한 항균 생분해성 조성물
WO2023016848A1 (en) * 2021-08-09 2023-02-16 Basf Se Sinter powder (sp) comprising at least one polylactide and at least one polycaprolactone
CN113908267B (zh) * 2021-11-30 2023-12-19 中国科学院长春应用化学研究所 一种疫苗佐剂及其制备方法和应用
FR3144996A1 (fr) * 2023-01-18 2024-07-19 Carbiolice Melange maitre enzyme comprenant des proteines

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100120243A (ko) 2002-05-07 2010-11-12 피시비다 유에스 인코포레이티드 약물 전달 장치를 형성하는 공정
US9555167B2 (en) 2006-12-11 2017-01-31 3M Innovative Properties Company Biocompatible antimicrobial compositions
US8846073B2 (en) * 2006-12-19 2014-09-30 Allergan, Inc. Low temperature processes for making cyclic lipid implants for intraocular use
TWI542338B (zh) 2008-05-07 2016-07-21 壯生和壯生視覺關懷公司 用於活性劑之控制釋放的眼用裝置
HUE033386T2 (en) * 2010-07-09 2017-11-28 Innocore Tech B V Release of Biodegradable Phase Separated Segmented Multiblock Copolymers and Biologically Active Polypeptides
CN102440966A (zh) * 2010-10-06 2012-05-09 段明华 艾塞那肽缓释制剂的制备工艺研究
FR2984354A1 (fr) 2011-12-20 2013-06-21 Centre Nat Rech Scient Procede de preparation d'alliage polymere/enzymes
JP2015536726A (ja) 2012-11-14 2015-12-24 オーソペディック イノヴェイション センター インコーポレイテッド 付加製造で製造する抗菌性物品
US20150001020A1 (en) * 2013-06-26 2015-01-01 King Fahd University Of Petroleum And Minerals Luggage sliders
FR3008093B1 (fr) * 2013-07-04 2015-12-11 Rhodia Operations Procede de fluoration de composes halogenures de sulfonyle
WO2015051020A1 (en) * 2013-10-03 2015-04-09 Polyone Corporation Antimicrobial polymer concentrates and compounds
US20160280881A1 (en) 2013-11-05 2016-09-29 Carbios A method for degrading a plastic
CN105330956A (zh) * 2014-08-07 2016-02-17 普立万聚合体（上海）有限公司 含对热敏感的功能添加剂的母料
US10626242B2 (en) 2014-12-19 2020-04-21 Carbios Plastic compound and preparation process
PL3307812T3 (pl) 2015-06-12 2024-10-07 Carbios Biodegradowalna kompozycja poliestru i jej zastosowania
WO2017081692A2 (en) 2015-11-12 2017-05-18 Curical Technologies Ltd. Biocompatible articles with embedded copper ions and copper ion releasing coating
MX2020000738A (es) 2017-07-25 2020-08-17 PK Med SAS Composicion de suministro de farmaco.

Also Published As

Publication number Publication date
JP7373486B2 (ja) 2023-11-02
SG11202000497VA (en) 2020-02-27
EP3658117A1 (en) 2020-06-03
KR20200040776A (ko) 2020-04-20
RU2020107391A (ru) 2021-08-25
CN111065378A (zh) 2020-04-24
BR112020001262A2 (pt) 2020-07-21
RU2020107391A3 (es) 2021-10-20
WO2019020678A1 (en) 2019-01-31
US11911476B2 (en) 2024-02-27
CA3069399A1 (en) 2019-01-31
JP2020528459A (ja) 2020-09-24
US20200368357A1 (en) 2020-11-26
ZA202001046B (en) 2022-10-26
AU2018305160A1 (en) 2020-01-30

Similar Documents

Publication Publication Date Title
MX2020000807A (es) Proceso para preparar una composicion de entrega de farmaco.
WO2015183369A3 (en) Process for fabricating carbon-carbon composites
CN104479282B (zh) 一种用于3d打印的玻璃纤维复合材料及其制备方法
MX2017011379A (es) Biocompuestos biodegradables a base de polímeros con propiedades a la medida y el metodo para fabricarlos.
MX2019011097A (es) Composicion de poliamida semicristalina con alta temperatura de transicion vitrea y alta temperatura de fusion para un material termoplastico, metodo de produccion y uso del mismo.
EP4245802A3 (en) Method for manufacturing molded components
BR112017010879A2 (pt) processo para fabricação de peça compósita complexa, notadamente com matriz termoplástica e peça obtida por esse processo
MX343263B (es) Fibras de acido polilactico endurecidas.
MX2024010581A (es) Compuestos de moldeo reforzados con fibra y metodos de formacion y uso de los mismos.
MX2019011098A (es) Composicion de poliamida semicristalina con base diamina corta que tiene una alta temperatura de transicion vitrea para material termoplastico, metodo de produccion y uso del mismo.
JP2016536391A5 (es)
MX2017004280A (es) Preparacion de lote maestro a base de azufre y nano-rellenadores carbonosos, lote maestro producido, y usos del mismo.
ES2720960T3 (es) Composición de polímero procesada por fusión derivada de vainas foliares de árboles del género Arecaceae
CN102702644A (zh) 冷弯电工护套管及其制造方法
CN102911425A (zh) 高熔体流动性挤出级超高分子量聚乙烯管材专用料及其制备方法
CN107987427A (zh) 一种新型高分子聚氯乙烯材料
BR112017016004A2 (pt) ?método para produzir um produto moldado por injeção, e, uso de fibras de casca de semente de girassol?
CN104371219A (zh) 一种医用耐热耐老化复合塑料及其制备方法
CA2983406A1 (en) Process for manufacturing of a fibre-reinforced polymer composition
MX2020013232A (es) Composiciones de copolimero de propileno adecuadas para formacion de espuma.
EA201170751A1 (ru) Стироловые полимеры для литья под давлением с раздувом и ориентированием и способы их получения и применения
CN105885395B (zh) 一种用于3d打印的共聚尼龙6组合物及其制备方法
CN104140628A (zh) 一种cpvc电力电缆保护管的制备方法
CN104527101A (zh) 一种r-pvc扭结膜的生产工艺
CN105237947A (zh) 耐磨塑料袋及其制备方法